We initiate the coverage of Sandoz, a Swiss generics/biosimilars giant, with a BUY recommendation.

Stellantis shares had a formidable run over the past twelve months, unlike most of its peers, and so ...

The emergence of SHEIN has posed a substantial threat to the Western fashion market (Inditex, H&...

Against all odds, the Metals & Mining sector is trying for another comeback and we are optimistic

What do we think of Casino's new ownership chance and restructuring plan? Is it worth a look?

As Exor's investor day is approaching fast, our holding company analyst Saïma HUSSAI...